| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 65.471 | 162.910 | 316.894 | 396.767 | 806.690 | 815.400 | 1.181.394 | 1.718.423 | 2.627.495 | 3.360.862 |
| Total Income - EUR | 65.549 | 163.463 | 317.762 | 397.767 | 809.194 | 826.166 | 1.299.485 | 1.718.643 | 2.631.649 | 3.366.728 |
| Total Expenses - EUR | 58.567 | 137.770 | 245.665 | 330.893 | 651.473 | 664.508 | 1.064.461 | 1.482.991 | 2.123.208 | 2.664.958 |
| Gross Profit/Loss - EUR | 6.983 | 25.694 | 72.097 | 66.874 | 157.722 | 161.659 | 235.024 | 235.652 | 508.441 | 701.770 |
| Net Profit/Loss - EUR | 5.018 | 22.543 | 69.517 | 62.907 | 149.655 | 154.112 | 220.411 | 195.381 | 395.779 | 595.398 |
| Employees | 1 | 2 | 4 | 5 | 8 | 10 | 11 | 14 | 15 | 18 |
Check the financial reports for the company - Ortoplus Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 722 | 463 | 11.156 | 20.512 | 43.338 | 33.681 | 47.826 | 80.953 | 76.015 | 69.800 |
| Current Assets | 39.406 | 62.809 | 125.465 | 193.962 | 344.695 | 558.398 | 615.130 | 587.858 | 786.188 | 1.036.354 |
| Inventories | 18.053 | 28.091 | 36.365 | 53.671 | 80.951 | 127.567 | 203.965 | 241.157 | 400.020 | 570.985 |
| Receivables | 19.304 | 26.889 | 73.030 | 106.502 | 188.427 | 242.863 | 364.705 | 291.809 | 343.569 | 406.037 |
| Cash | 2.049 | 7.829 | 16.070 | 33.789 | 75.318 | 187.968 | 46.460 | 54.892 | 42.598 | 59.332 |
| Shareholders Funds | 1.262 | 23.793 | 87.081 | 148.390 | 288.401 | 393.086 | 482.373 | 479.674 | 686.207 | 873.344 |
| Social Capital | 90 | 89 | 88 | 86 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 38.866 | 39.478 | 49.540 | 66.084 | 99.633 | 80.283 | 180.583 | 189.137 | 175.996 | 235.451 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 118.710 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Ortoplus Pharma Srl